Literature DB >> 21205965

Non-evidence-based ICD implantations in the United States.

Sana M Al-Khatib1, Anne Hellkamp, Jeptha Curtis, Daniel Mark, Eric Peterson, Gillian D Sanders, Paul A Heidenreich, Adrian F Hernandez, Lesley H Curtis, Stephen Hammill.   

Abstract

CONTEXT: Practice guidelines do not recommend use of an implantable cardioverter-defibrillator (ICD) for primary prevention in patients recovering from a myocardial infarction or coronary artery bypass graft surgery and those with severe heart failure symptoms or a recent diagnosis of heart failure.
OBJECTIVE: To determine the number, characteristics, and in-hospital outcomes of patients who receive a non-evidence-based ICD and examine the distribution of these implants by site, physician specialty, and year of procedure. DESIGN, SETTING, AND PATIENTS: Retrospective cohort study of cases submitted to the National Cardiovascular Data Registry-ICD Registry between January 1, 2006, and June 30, 2009. MAIN OUTCOME MEASURE: In-hospital outcomes.
RESULTS: Of 111,707 patients, 25,145 received non-evidence-based ICD implants (22.5%). Patients who received a non-evidence-based ICD compared with those who received an evidence-based ICD had a significantly higher risk of in-hospital death (0.57% [95% confidence interval {CI}, 0.48%-0.66%] vs 0.18% [95% CI, 0.15%-0.20%]; P <.001) and any postprocedure complication (3.23% [95% CI, 3.01%-3.45%] vs 2.41% [95% CI, 2.31%-2.51%]; P <.001). There was substantial variation in non-evidence-based ICDs by site. The rate of non-evidence-based ICD implants was significantly lower for electrophysiologists (20.8%; 95% CI, 20.5%-21.1%) than nonelectrophysiologists (24.8% [95% CI, 24.2%-25.3%] for nonelectrophysiologist cardiologists; 36.1% [95% CI, 34.3%-38.0%] for thoracic surgeons; and 24.9% [95% CI, 23.8%-25.9%] for other specialties) (P<.001 for all comparisons). There was no clear decrease in the rate of non-evidence-based ICDs over time (24.5% [6908/28,233] in 2006, 21.8% [7395/33,965] in 2007, 22.0% [7245/32,960] in 2008, and 21.7% [3597/16,549] in 2009; P <.001 for trend from 2006-2009 and P = .94 for trend from 2007-2009).
CONCLUSION: Among patients with ICD implants in this registry, 22.5% did not meet evidence-based criteria for implantation.

Entities:  

Mesh:

Year:  2011        PMID: 21205965      PMCID: PMC3432303          DOI: 10.1001/jama.2010.1915

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

1.  Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.

Authors:  Stephen C Hammill; Mark S Kremers; Alan H Kadish; Lynne Warner Stevenson; Paul A Heidenreich; Bruce D Lindsay; Michael J Mirro; Martha J Radford; Chuck McKay; Yongfei Wang; Christine M Lang; Kathryn Pontzer; John Rumsfeld; Steve E Phurrough; Jeptha P Curtis; Ralph G Brindis
Journal:  Heart Rhythm       Date:  2009-07-16       Impact factor: 6.343

2.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

3.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

Authors:  Stefan H Hohnloser; Karl Heinz Kuck; Paul Dorian; Robin S Roberts; John R Hampton; Robert Hatala; Eric Fain; Michael Gent; Stuart J Connolly
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.

Authors:  J T Bigger
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

6.  Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Authors:  Jeptha P Curtis; Jeffrey J Luebbert; Yongfei Wang; Saif S Rathore; Jersey Chen; Paul A Heidenreich; Stephen C Hammill; Rachel I Lampert; Harlan M Krumholz
Journal:  JAMA       Date:  2009-04-22       Impact factor: 56.272

7.  Defibrillator implantation early after myocardial infarction.

Authors:  Gerhard Steinbeck; Dietrich Andresen; Karlheinz Seidl; Johannes Brachmann; Ellen Hoffmann; Dariusz Wojciechowski; Zdzisława Kornacewicz-Jach; Beata Sredniawa; Géza Lupkovics; Franz Hofgärtner; Andrzej Lubinski; Mårten Rosenqvist; Alphonsus Habets; Karl Wegscheider; Jochen Senges
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

8.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

9.  Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005.

Authors:  Sana M Al-Khatib; Melissa A Greiner; Eric D Peterson; Adrian F Hernandez; Kevin A Schulman; Lesley H Curtis
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-10

10.  Ethnic and racial disparities in cardiac resynchronization therapy.

Authors:  Steven A Farmer; James N Kirkpatrick; Paul A Heidenreich; Jeptha P Curtis; Yongfei Wang; Peter W Groeneveld
Journal:  Heart Rhythm       Date:  2008-12-13       Impact factor: 6.343

View more
  66 in total

Review 1.  Opportunities for cost reduction of medical care: part 3.

Authors:  Monte Malach; William J Baumol
Journal:  J Community Health       Date:  2012-08

2.  Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.

Authors:  Jorge M Castellanos; Lisa M Smith; Paul D Varosy; Christine Dehlendorf; Gregory M Marcus
Journal:  Heart Rhythm       Date:  2012-02-02       Impact factor: 6.343

3.  Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?

Authors:  Sana M Al-Khatib; Anne S Hellkamp; Adrian F Hernandez; Gregg C Fonarow; Kevin L Thomas; Hussein R Al-Khalidi; Paul A Heidenreich; Stephen Hammill; Clyde Yancy; Eric D Peterson
Journal:  Circulation       Date:  2012-01-27       Impact factor: 29.690

4.  Not by bread alone: shortcomings of the pay-for-performance approach.

Authors:  Joseph Bernstein
Journal:  Clin Orthop Relat Res       Date:  2013-12-12       Impact factor: 4.176

5.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

6.  Estimating the adoption of transcatheter aortic valve replacement by US interventional cardiologists and clinical trialists.

Authors:  Joshua M Stolker; Akshar Y Patel; Michael J Lim; Paul J Hauptman
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

Review 7.  Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.

Authors:  Yitschak Biton; Jayson R Baman; Bronislava Polonsky
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

8.  Twenty-five years of implantable defibrillator practice in the USA: are we ready for globalization?

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2011-01       Impact factor: 1.900

9.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

Review 10.  The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis.

Authors:  Attila Roka; Mark H Schoenfeld
Journal:  J Interv Card Electrophysiol       Date:  2012-12-15       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.